Exclusive

Publication

Byline

Japan's Third Way: BioJapan Day 2 Maps the Routes Out and the Reasons to Come In

Singapore, Oct. 8 -- If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIFICO Yokohama got down to the practical business of closing ... Read More


Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies

Singapore, Oct. 8 -- Andelyn Biosciences ("Andelyn"), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and PQP Group announced a s... Read More


Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

Singapore, Oct. 7 -- China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a licensing and option agreement with Novartis to advance ... Read More


AstraZeneca opens new global strategic R&D centre in Massachusetts, US

Singapore, Oct. 7 -- AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US. The new state-of-the-... Read More


Docquity extends Asian healthcare intelligence to Japan through deepened strategic partnership with exMedio

Singapore, Oct. 7 -- Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale up plan into Japan through a deepened strategic partn... Read More


Qiagen expands AI-powered bioinformatics for research and drug discovery

Singapore, Oct. 7 -- Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and genomic data faster while keeping the scientific evidence beh... Read More


Singapore injects S$50 M into National Centre for Engineering Biology

Singapore, Oct. 6 -- The National Centre for Engineering Biology (NCEB), hosted at the National University of Singapore (NUS), has been officially launched together with its new research facility. De... Read More


Japan-Ghana partnership to advance next-generation vaccine R&D

Singapore, Oct. 6 -- Japan-based Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), led by Director Hiroshi Kiyono, has signed a Memorandum of Unders... Read More


Merck inks up to $2.13 B oncology deal with China's SciBrunch

Singapore, Oct. 6 -- Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered into an exclusive global license agreement for SPR2015, an... Read More


Taiwan's Energenesis Biomedical joins hands with Korea-based Yoo Young Pharm to develop treatment for diabetic foot ulcers

Singapore, Oct. 6 -- Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South Korea-based pharmaceutical company, to explore a collaborati... Read More